{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:46:07Z","timestamp":1774655167175,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymgmr.2020.100565","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T23:22:45Z","timestamp":1581722565000},"page":"100565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Natural history of the late-onset phenotype of Fabry disease due to the p.F113L mutation"],"prefix":"10.1016","volume":"22","author":[{"given":"Olga","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel F.","family":"Gago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Miltenberger-Miltenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Raquel","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ant\u00f3nia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Teresa","family":"Vide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo","family":"Castelo Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f3nia","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dami\u00e3o","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2020.100565_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphan. J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry outcome survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0015","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193550","article-title":"Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation","volume":"13","author":"Lavalle","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2020.100565_bb0030","article-title":"Founder effect of Fabry disease due to p.F113L mutation: clinical profile of a late-onset phenotype","author":"Azevedo","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.amjhyper.2006.01.011","article-title":"Prevalence of uncontrolled hypertension in patients with Fabry disease","volume":"19","author":"Kleinert","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10545-017-0127-2","article-title":"Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease","volume":"41","author":"Alharbi","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001691","article-title":"\u03b1-Galactosidase A genotype N215S induces a specific cardiac variant of fabry disease","volume":"10","author":"Oder","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003146","article-title":"Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A)","volume":"3","author":"Lin","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ymgmr.2020.100565_bb0055","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3174\/ajnr.A4677","article-title":"Brain MR imaging findings of cardiac-type Fabry disease with an IVS4+919G>A mutation","volume":"37","author":"Lee","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-017-0810-9","article-title":"A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>a mutation","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.389","article-title":"Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: a multicenter Fabry registry study","author":"Germain","year":"2018","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0070","first-page":"107","article-title":"Age at first cardiac symptoms in Fabry disease: association with a Chinese hotspot Fabry mutation (IVS4+919G>A), classical Fabry mutations, and sex in a Taiwanese population from the Fabry outcome survey (FOS)","volume":"22","author":"Liu","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10545-010-9166-7","article-title":"Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4+919G\u2192A)","volume":"33","author":"Lin","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant \u03b1-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"Ishii","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0085","first-page":"28","article-title":"Miocardiopatia Hipertr\u00f3fica secund\u00e1ria a doen\u00e7a de Fabry: Evid\u00eancia de um efeito fundador na regi\u00e3o de Guimar\u00e3es [Abstract]","volume":"32","author":"Azevedo","year":"2013","journal-title":"Rev. Port. Cardiol."},{"issue":"5","key":"10.1016\/j.ymgmr.2020.100565_bb0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/10976640500295516","article-title":"Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging","volume":"7","author":"Hudsmith","year":"2005","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0095","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2016.09.943","article-title":"Later onset Fabry disease, cardiac damage progress in silence: experience with a highly prevalent mutation","volume":"68","author":"Hsu","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ymgmr.2020.100565_bb0105","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphan. J. Rare Dis."},{"issue":"7 Pt 1","key":"10.1016\/j.ymgmr.2020.100565_bb0110","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ymgmr.2020.100565_bb0115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10545-012-9540-8","article-title":"Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease","volume":"36","author":"Niemann","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0125","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4103\/1673-5374.241465","article-title":"Prevalence of white matter hyperintensities increases with age","volume":"13","author":"Zhuang","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000368814","article-title":"The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC study","volume":"16","author":"Liao","year":"1997","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ymgmr.2020.100565_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0140","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2017.05.001","article-title":"Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry disease","volume":"121","author":"Arends","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100565_bb0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ejechocard\/jer109","article-title":"Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease","volume":"12","author":"Zamorano","year":"2011","journal-title":"Eur. J. Echocardiogr."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426919302113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426919302113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:30Z","timestamp":1762001490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426919302113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"alternative-id":["S2214426919302113"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100565","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of the late-onset phenotype of Fabry disease due to the p.F113L mutation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100565"}}